Sangamo Therapeutics
SGMO
#9879
Rank
ยฃ40.64 M
Marketcap
ยฃ0.09812
Share price
-5.46%
Change (1 day)
-70.33%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ72.47 Million, an increase over its 2023 earnings that were of -ยฃ87.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million14.67%
2024 -ยฃ72.47 Million-17.27%
2023 -ยฃ87.59 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ95.36 Million23.17%
2019 -ยฃ77.42 Million36.33%
2018 -ยฃ56.79 Million36.89%
2017 -ยฃ41.49 Million-22.32%
2016 -ยฃ53.41 Million54.86%
2015 -ยฃ34.49 Million75.62%
2014 -ยฃ19.64 Million0.13%
2013 -ยฃ19.62 Million
2011 -ยฃ26.37 Million43.66%
2010 -ยฃ18.36 Million28.52%
2009 -ยฃ14.29 Million-23.55%
2008 -ยฃ18.68 Million2.45%
2007 -ยฃ18.24 Million19.5%
2006 -ยฃ15.26 Million50.78%
2005 -ยฃ10.12 Million75%
2004 -ยฃ5.79 Million-33.25%
2003 -ยฃ8.67 Million-62.27%
2002 -ยฃ22.97 Million102.82%
2001 -ยฃ11.33 Million23.21%
2000 -ยฃ9.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.12 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.68 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.19 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.87 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.21 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.68 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.64 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA